Wall Street analysts expect Perrigo (NYSE:PRGO) to post $1.14 earnings per share for the current quarter, according to Zacks. Sixteen analysts have made estimates for Perrigo’s earnings. The highest EPS estimate is $1.22 and the lowest is $1.01. Perrigo posted earnings of $1.05 per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 8.6%. The firm is scheduled to issue its next earnings report on Tuesday, May 29th.
According to Zacks, analysts expect that Perrigo will report full year earnings of $5.23 per share for the current fiscal year, with EPS estimates ranging from $5.07 to $5.32. For the next financial year, analysts expect that the firm will post earnings of $5.74 per share, with EPS estimates ranging from $5.47 to $6.13. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research firms that cover Perrigo.
Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Thursday, March 1st. The company reported $1.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.25 by $0.03. Perrigo had a return on equity of 11.54% and a net margin of 2.42%. The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same period last year, the company earned $1.24 EPS. Perrigo’s revenue for the quarter was down 3.6% compared to the same quarter last year.
A number of equities research analysts have recently weighed in on the company. Cantor Fitzgerald set a $107.00 price objective on Perrigo and gave the stock a “buy” rating in a research report on Friday, January 12th. Canaccord Genuity reiterated a “buy” rating and issued a $100.00 price objective on shares of Perrigo in a research report on Wednesday, January 17th. Berenberg Bank assumed coverage on Perrigo in a research report on Thursday, February 1st. They issued a “buy” rating and a $117.00 price objective on the stock. Finally, Leerink Swann assumed coverage on Perrigo in a research report on Tuesday, January 2nd. They issued a “market perform” rating and a $90.00 price objective on the stock. One research analyst has rated the stock with a sell rating, ten have given a hold rating and nine have assigned a buy rating to the stock. Perrigo presently has a consensus rating of “Hold” and an average target price of $91.88.
PRGO opened at $80.86 on Friday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.40 and a current ratio of 1.96. Perrigo has a 1 year low of $63.68 and a 1 year high of $95.93. The company has a market cap of $11,539.91, a P/E ratio of 16.40, a P/E/G ratio of 2.03 and a beta of 0.76.
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 2nd were paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.94%. The ex-dividend date was Thursday, March 1st. This is a boost from Perrigo’s previous quarterly dividend of $0.16. Perrigo’s dividend payout ratio (DPR) is presently 15.42%.
In other news, CEO Uwe Roehrhoff bought 7,500 shares of the stock in a transaction dated Monday, March 5th. The stock was bought at an average price of $81.85 per share, for a total transaction of $613,875.00. Following the purchase, the chief executive officer now directly owns 4,900 shares in the company, valued at approximately $401,065. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 6.90% of the company’s stock.
Several institutional investors and hedge funds have recently added to or reduced their stakes in PRGO. Dupont Capital Management Corp purchased a new position in Perrigo during the fourth quarter valued at $104,000. ARP Americas LP purchased a new position in Perrigo during the fourth quarter valued at $212,000. Quantitative Systematic Strategies LLC purchased a new position in Perrigo during the fourth quarter valued at $213,000. Investors Research Corp purchased a new position in Perrigo during the fourth quarter valued at $214,000. Finally, V Wealth Management LLC purchased a new position in Perrigo during the fourth quarter valued at $214,000. Institutional investors own 79.11% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://ledgergazette.com/2018/04/20/analysts-anticipate-perrigo-prgo-will-announce-earnings-of-1-14-per-share.html.
Perrigo Company Profile
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.